CCN4 and melanoma: Using the B16 model for melanoma, we identified that tumor-derived Wnt-inducible signaling protein 1 (WISP1), a beta-catenin responsive oncogene [26], exerts paracrine action on immune cells by inhibiting their functional response to IL12 [27].